XML 17 R10.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Investments | 6 Months Ended
--- | ---
Jun. 30, 2024
Investments, Debt and Equity Securities [Abstract] |
Investments | Note 3—Investments Investments are as follows (in millions):
|  | June 30, |  |  | December 31, |
|  | 2024 |  |  | 2023 |
Non-marketable equity securities |  | $ | 124.0 |  |  | $ | 124.0 |
Seed capital investments |  |  | 25.9 |  |  |  | 26.1 |
Marketable equity securities |  |  | 20.6 |  |  |  | 23.1 |
Partnership interests in private equity funds |  |  | 10.7 |  |  |  | 11.5 |
Total investments |  | $ | 181.2 |  |  | $ | 184.7 |
There were no realized gains or losses for our equity securities in the three and six months ended June 30, 2024 and 2023. Unrealized gains for our equity securities are as follows (in millions):
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Unrealized (losses) gains on equity securities held as of the end of the period |  | $ | (0.7 | ) |  | $ | 0.9 |  |  | $ | 0.2 |  |  | $ | 3.2 |
Fair Value Measurement Authoritative accounting guidance on fair value measurements establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions. As of June 30, 2024 and December 31, 2023, we held certain investment assets and certain liabilities that are required to be measured at fair value on a recurring basis. These investments include money market funds and marketable equity securities where fair value is determined using quoted prices in active markets. Accordingly, the fair value measurements of these investments have been classified as Level 1 in the tables below. Investments for which we elected net asset value as a practical expedient for fair value and investments measured using the fair value measurement alternative are excluded from the tables below. Fair value for deferred compensation liabilities that are credited with deemed gains or losses of the underlying hypothetical investments, primarily equity securities, have been classified as Level 1 in the tables below. The following tables present assets and liabilities measured at fair value on a recurring basis (in millions):
|  |  |  |  | Fair Value Measurements at Reporting Date Using |
|  | June 30, 2024 |  |  | Quoted prices in Active Markets for Identical Assets (Level 1) |  |  | Significant Other Observable Inputs (Level 2) |  |  | Significant Unobservable Inputs (Level 3) |
Money market funds (1) |  | $ | 1,420.2 |  |  | $ | 1,420.2 |  |  | $ | — |  |  | $ | — |
Seed capital investments (2) |  |  | 25.9 |  |  |  | 25.9 |  |  |  | — |  |  |  | — |
Marketable equity securities (2) |  |  | 20.6 |  |  |  | 20.6 |  |  |  | — |  |  |  | — |
Deferred compensation liabilities (3) |  |  | (11.6 | ) |  |  | (11.6 | ) |  |  | — |  |  |  | — |
Total |  | $ | 1,455.1 |  |  | $ | 1,455.1 |  |  | $ | — |  |  | $ | — |
|  |  |  |  | Fair Value Measurements at Reporting Date Using |
|  | December 31, 2023 |  |  | Quoted prices in Active Markets for Identical Assets (Level 1) |  |  | Significant Other Observable Inputs (Level 2) |  |  | Significant Unobservable Inputs (Level 3) |
Money market funds (1) |  | $ | 2,212.6 |  |  | $ | 2,212.6 |  |  | $ | — |  |  | $ | — |
Seed capital investments (2) |  |  | 26.1 |  |  |  | 26.1 |  |  |  | — |  |  |  | — |
Marketable equity securities (2) |  |  | 23.1 |  |  |  | 23.1 |  |  |  | — |  |  |  | — |
Deferred compensation liabilities (3) |  |  | (11.7 | ) |  |  | (11.7 | ) |  |  | — |  |  |  | — |
Total |  | $ | 2,250.1 |  |  | $ | 2,250.1 |  |  | $ | — |  |  | $ | — |
(1) As of June 30, 2024, included $130.8 million of cash and cash equivalents, $2.6 million of restricted cash and $1,286.8 million of funds receivable and funds held on behalf of clients on the Condensed Consolidated Balance Sheet. As of December 31, 2023, included $131.7 million of cash and cash equivalents, $1.8 million of restricted cash and $2,079.1 million of funds receivable and funds held on behalf of clients on the Condensed Consolidated Balance Sheet. (2) Included in Investments on the Condensed Consolidated Balance Sheet. (3) Included in Other long-term liabilities on the Condensed Consolidated Balance Sheet. We have partnership interests in various private equity funds that are not included in the tables above. Our inve stments in private equity funds were $10.7 million and $11.5 million at June 30, 2024 and December 31, 2023, respectively, of which $9.2 million in each year, were measured using net asset value as a practical expedient for fair value and $1.5 m illion and $2.3 million, respectively, were accounted for under the equity method of accounting. The investments in private equity funds represent underlying investments in domestic and international markets across various industry sectors. Generally, our investments in private equity funds are non-transferable or are subject to long holding periods, and withdrawals from the private equity firm partnerships are typically not permitted. The maximum risk of loss related to our private equity fund investments is limited to the carrying value of its investments in the entities.

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for investments in certain debt and equity securities. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 940 -SubTopic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/940-320/tableOfContent Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name Regulation S-K (SK) -Number 229 -Section 1403 -Paragraph b -Publisher SEC Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/320/tableOfContent Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-10 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6B -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6B -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/942-320/tableOfContent + Details
Name: | us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration